Early detection of Alzheimer's disease (AD) is essential for improving the patients outcomes
and advancing our understanding of disease, allowing for timely intervention and treatment …

The mechanisms that confer cognitive resilience to Alzheimer's Disease (AD) are not fully
understood. Here, we describe a neural circuit mechanism underlying this resilience in a …

The presymptomatic phase of Alzheimer disease (AD) starts with the deposition of amyloid-β
in the cortex and begins a decade or more before the emergence of cognitive decline. The …

Brain rhythms provide the timing for recruitment of brain activity required for linking together
neuronal ensembles engaged in specific tasks. The γ-oscillations (30 to 120 Hz) orchestrate …

Alzheimer's disease (AD) is the most common cause of dementia. Epileptic seizures or
epileptic activity have been detected in AD, and people with epilepsy have a higher risk of …

Aims Alzheimer's disease (AD) is a leading cause of dementia, with increasing prevalence.
Mutations in genes like MAPT, PSEN1, and PSEN2 are risk factors, leading to the …

INTRODUCTION The use of anti‐epileptic drugs (AEDs) in degenerative dementia (DD)
remains uncertain. We aimed to evaluate the association of early AED administration with …

Brain rhythms provide the timing and concurrence of brain activity required for linking
together neuronal ensembles engaged in specific tasks. In particular, the γ-oscillations (30 …

Treatment with melatonin is routinely prescribed for its potent antioxidant and cognitive‐
promoting effects, nevertheless, it has yet to find neuromodulatory effects in normal and …

The impact of apolipoprotein E4 (apoE4), the strongest genetic risk factor for Alzheimer's
disease (AD), on neuronal function remains unclear. We investigated this by examining …